HEADER VIRAL PROTEIN 03-DEC-14 4UC8 TITLE N-TERMINAL GLOBULAR DOMAIN OF THE RSV NUCLEOPROTEIN IN COMPLEX WITH C- TITLE 2 TERMINAL PHENYLALANINE OF THE PHOSPHOPROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEOPROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: N-TERMINAL GLOBULAR DOMAIN, RESIDUES 31-252; COMPND 5 SYNONYM: PROTEIN N, NUCLEOCAPSID PROTEIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN RESPIRATORY SYNCYTIAL VIRUS A2; SOURCE 3 ORGANISM_TAXID: 11259; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS VIRAL PROTEIN, RIBONUCLEOPROTEIN, NUCLEOCAPSID, PHOSPHOPROTEIN, KEYWDS 2 ANTIVIRAL COMPOUNDS, HALOGEN BOND EXPDTA X-RAY DIFFRACTION AUTHOR M.OUIZOUGUN-OUBARI,N.PEREIRA,B.TARUS,M.GALLOUX,M.-A.TORTORICI,S.HOOS, AUTHOR 2 B.BARON,P.ENGLAND,F.BONTEMS,F.A.REY,J.-F.ELEOUET,C.SIZUN,A.SLAMA- AUTHOR 3 SCHWOK,S.DUQUERROY REVDAT 3 20-DEC-23 4UC8 1 REMARK REVDAT 2 14-OCT-15 4UC8 1 JRNL REVDAT 1 19-AUG-15 4UC8 0 JRNL AUTH M.OUIZOUGUN-OUBARI,N.PEREIRA,B.TARUS,M.GALLOUX,S.LASSOUED, JRNL AUTH 2 J.FIX,M.A.TORTORICI,S.HOOS,B.BARON,P.ENGLAND,D.DESMAELE, JRNL AUTH 3 P.COUVREUR,F.BONTEMS,F.A.REY,J.F.ELEOUET,C.SIZUN, JRNL AUTH 4 A.SLAMA-SCHWOK,S.DUQUERROY JRNL TITL A DRUGGABLE POCKET AT THE NUCLEOCAPSID/PHOSPHOPROTEIN JRNL TITL 2 INTERACTION SITE OF THE HUMAN RESPIRATORY SYNCYTIAL VIRUS. JRNL REF J.VIROL. V. 89 11129 2015 JRNL REFN ISSN 0022-538X JRNL PMID 26246564 JRNL DOI 10.1128/JVI.01612-15 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 88.2 REMARK 3 NUMBER OF REFLECTIONS : 29743 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.180 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.212 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 1507 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.07 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 88.19 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2003 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2198 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1888 REMARK 3 BIN R VALUE (WORKING SET) : 0.2198 REMARK 3 BIN FREE R VALUE : 0.2193 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.74 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 115 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3470 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 272 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 29.47 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.65 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.61100 REMARK 3 B22 (A**2) : 2.73310 REMARK 3 B33 (A**2) : -7.34410 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.248 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.205 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.163 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.192 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.159 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.938 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3651 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4920 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1308 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 84 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 531 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3651 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 481 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : 6 ; 1.000 ; HARMONIC REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4361 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.00 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.82 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.58 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): 12.2176 16.5123 0.0659 REMARK 3 T TENSOR REMARK 3 T11: -0.1232 T22: -0.1371 REMARK 3 T33: -0.1105 T12: -0.0058 REMARK 3 T13: -0.0180 T23: -0.0370 REMARK 3 L TENSOR REMARK 3 L11: 3.0296 L22: 2.4148 REMARK 3 L33: 1.7526 L12: -0.9019 REMARK 3 L13: -0.5770 L23: 0.6014 REMARK 3 S TENSOR REMARK 3 S11: 0.1113 S12: 0.2349 S13: -0.3122 REMARK 3 S21: -0.1813 S22: -0.0630 S23: 0.1926 REMARK 3 S31: -0.0444 S32: -0.0923 S33: -0.0483 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 9.7366 48.0621 -24.1248 REMARK 3 T TENSOR REMARK 3 T11: -0.1047 T22: -0.1269 REMARK 3 T33: -0.0987 T12: -0.0035 REMARK 3 T13: -0.0016 T23: 0.0025 REMARK 3 L TENSOR REMARK 3 L11: 1.4685 L22: 1.4490 REMARK 3 L33: 1.3675 L12: -0.0033 REMARK 3 L13: -0.1270 L23: 0.4356 REMARK 3 S TENSOR REMARK 3 S11: -0.0031 S12: 0.1271 S13: 0.0670 REMARK 3 S21: -0.0032 S22: -0.0428 S23: 0.0465 REMARK 3 S31: -0.0612 S32: 0.0487 S33: 0.0459 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP. REMARK 3 ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY REMARK 4 REMARK 4 4UC8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-DEC-14. REMARK 100 THE DEPOSITION ID IS D_1290062444. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SOLEIL REMARK 200 BEAMLINE : PROXIMA 1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29895 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.4 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 61.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.40000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2WJ8 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.48 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 35.90400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 67.36150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 35.90400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 67.36150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 28 REMARK 465 GLY A 29 REMARK 465 SER A 30 REMARK 465 ASP A 31 REMARK 465 GLU A 254 REMARK 465 HIS A 255 REMARK 465 HIS A 256 REMARK 465 HIS A 257 REMARK 465 HIS A 258 REMARK 465 HIS A 259 REMARK 465 HIS A 260 REMARK 465 MET B 28 REMARK 465 GLY B 29 REMARK 465 SER B 30 REMARK 465 LEU B 253 REMARK 465 GLU B 254 REMARK 465 HIS B 255 REMARK 465 HIS B 256 REMARK 465 HIS B 257 REMARK 465 HIS B 258 REMARK 465 HIS B 259 REMARK 465 HIS B 260 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 91 CG CD CE NZ REMARK 470 LYS A 107 CG CD CE NZ REMARK 470 LEU A 253 CG CD1 CD2 REMARK 470 ASP B 85 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 171 -60.93 -128.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PHE A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1254 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1255 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1256 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PHE B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1253 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1254 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1255 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1256 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1257 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 1258 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 1259 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4UC6 RELATED DB: PDB REMARK 900 N-TERMINAL GLOBULAR DOMAIN OF THE RSV NUCLEOPROTEIN REMARK 900 RELATED ID: 4UC7 RELATED DB: PDB REMARK 900 N-TERMINAL GLOBULAR DOMAIN OF THE RSV NUCLEOPROTEIN REMARK 900 RELATED ID: 4UC9 RELATED DB: PDB REMARK 900 N-TERMINAL GLOBULAR DOMAIN OF THE RSV NUCLEOPROTEIN IN COMPLEX WITH REMARK 900 C-TERMINAL DIPEPTIDE OF THE PHOSPHOPROTEIN REMARK 900 RELATED ID: 4UCA RELATED DB: PDB REMARK 900 N-TERMINAL GLOBULAR DOMAIN OF THE RSV NUCLEOPROTEIN IN COMPLEX WITH REMARK 900 C-TERMINAL PEPTIDE OF THE PHOSPHOPROTEIN REMARK 900 RELATED ID: 4UCB RELATED DB: PDB REMARK 900 N-TERMINAL GLOBULAR DOMAIN OF THE RSV NUCLEOPROTEIN IN COMPLEX WITH REMARK 900 C-TERMINAL PEPTIDE OF THE PHOSPHOPROTEIN REMARK 900 RELATED ID: 4UCC RELATED DB: PDB REMARK 900 N-TERMINAL GLOBULAR DOMAIN OF THE RSV NUCLEOPROTEIN IN COMPLEX WITH REMARK 900 THE NUCLEOPROTEIN PHOSPHOPROTEIN INTERACTION INHIBITOR M76 REMARK 900 RELATED ID: 4UCD RELATED DB: PDB REMARK 900 N-TERMINAL GLOBULAR DOMAIN OF THE RSV NUCLEOPROTEIN IN COMPLEX WITH REMARK 900 THE NUCLEOPROTEIN PHOSPHOPROTEIN INTERACTION INHIBITOR M81 REMARK 900 RELATED ID: 4UCE RELATED DB: PDB REMARK 900 N-TERMINAL GLOBULAR DOMAIN OF THE RSV NUCLEOPROTEIN IN COMPLEX WITH REMARK 900 THE NUCLEOPROTEIN PHOSPHOPROTEIN INTERACTION INHIBITOR M72 REMARK 999 REMARK 999 SEQUENCE REMARK 999 N-TERMINAL MGS- AND C-TERMINAL -LEHHHHHH AMINO ACIDS COMES REMARK 999 FROM CLONING. SEQUENCE NUMBERING ACCORDING TO P03418 ENTRY. REMARK 999 REMARK 999 C-TERMINAL AMNINO-ACID OF THE RSV PHOSPHOPROTEIN. PHE A REMARK 999 301 WAS CO-CRYSTALLIZED WITH THE RSV NUCLEOPROTEIN. DBREF 4UC8 A 31 252 UNP P03418 NCAP_HRSVA 31 252 DBREF 4UC8 B 31 252 UNP P03418 NCAP_HRSVA 31 252 SEQADV 4UC8 MET A 28 UNP P03418 EXPRESSION TAG SEQADV 4UC8 GLY A 29 UNP P03418 EXPRESSION TAG SEQADV 4UC8 SER A 30 UNP P03418 EXPRESSION TAG SEQADV 4UC8 LEU A 253 UNP P03418 EXPRESSION TAG SEQADV 4UC8 GLU A 254 UNP P03418 EXPRESSION TAG SEQADV 4UC8 HIS A 255 UNP P03418 EXPRESSION TAG SEQADV 4UC8 HIS A 256 UNP P03418 EXPRESSION TAG SEQADV 4UC8 HIS A 257 UNP P03418 EXPRESSION TAG SEQADV 4UC8 HIS A 258 UNP P03418 EXPRESSION TAG SEQADV 4UC8 HIS A 259 UNP P03418 EXPRESSION TAG SEQADV 4UC8 HIS A 260 UNP P03418 EXPRESSION TAG SEQADV 4UC8 LYS A 234 UNP P03418 ARG 234 CONFLICT SEQADV 4UC8 MET B 28 UNP P03418 EXPRESSION TAG SEQADV 4UC8 GLY B 29 UNP P03418 EXPRESSION TAG SEQADV 4UC8 SER B 30 UNP P03418 EXPRESSION TAG SEQADV 4UC8 LEU B 253 UNP P03418 EXPRESSION TAG SEQADV 4UC8 GLU B 254 UNP P03418 EXPRESSION TAG SEQADV 4UC8 HIS B 255 UNP P03418 EXPRESSION TAG SEQADV 4UC8 HIS B 256 UNP P03418 EXPRESSION TAG SEQADV 4UC8 HIS B 257 UNP P03418 EXPRESSION TAG SEQADV 4UC8 HIS B 258 UNP P03418 EXPRESSION TAG SEQADV 4UC8 HIS B 259 UNP P03418 EXPRESSION TAG SEQADV 4UC8 HIS B 260 UNP P03418 EXPRESSION TAG SEQADV 4UC8 LYS B 234 UNP P03418 ARG 234 CONFLICT SEQRES 1 A 233 MET GLY SER ASP SER ILE ASP THR PRO ASN TYR ASP VAL SEQRES 2 A 233 GLN LYS HIS ILE ASN LYS LEU CYS GLY MET LEU LEU ILE SEQRES 3 A 233 THR GLU ASP ALA ASN HIS LYS PHE THR GLY LEU ILE GLY SEQRES 4 A 233 MET LEU TYR ALA MET SER ARG LEU GLY ARG GLU ASP THR SEQRES 5 A 233 ILE LYS ILE LEU ARG ASP ALA GLY TYR HIS VAL LYS ALA SEQRES 6 A 233 ASN GLY VAL ASP VAL THR THR HIS ARG GLN ASP ILE ASN SEQRES 7 A 233 GLY LYS GLU MET LYS PHE GLU VAL LEU THR LEU ALA SER SEQRES 8 A 233 LEU THR THR GLU ILE GLN ILE ASN ILE GLU ILE GLU SER SEQRES 9 A 233 ARG LYS SER TYR LYS LYS MET LEU LYS GLU MET GLY GLU SEQRES 10 A 233 VAL ALA PRO GLU TYR ARG HIS ASP SER PRO ASP CYS GLY SEQRES 11 A 233 MET ILE ILE LEU CYS ILE ALA ALA LEU VAL ILE THR LYS SEQRES 12 A 233 LEU ALA ALA GLY ASP ARG SER GLY LEU THR ALA VAL ILE SEQRES 13 A 233 ARG ARG ALA ASN ASN VAL LEU LYS ASN GLU MET LYS ARG SEQRES 14 A 233 TYR LYS GLY LEU LEU PRO LYS ASP ILE ALA ASN SER PHE SEQRES 15 A 233 TYR GLU VAL PHE GLU LYS HIS PRO HIS PHE ILE ASP VAL SEQRES 16 A 233 PHE VAL HIS PHE GLY ILE ALA GLN SER SER THR LYS GLY SEQRES 17 A 233 GLY SER ARG VAL GLU GLY ILE PHE ALA GLY LEU PHE MET SEQRES 18 A 233 ASN ALA TYR GLY LEU GLU HIS HIS HIS HIS HIS HIS SEQRES 1 B 233 MET GLY SER ASP SER ILE ASP THR PRO ASN TYR ASP VAL SEQRES 2 B 233 GLN LYS HIS ILE ASN LYS LEU CYS GLY MET LEU LEU ILE SEQRES 3 B 233 THR GLU ASP ALA ASN HIS LYS PHE THR GLY LEU ILE GLY SEQRES 4 B 233 MET LEU TYR ALA MET SER ARG LEU GLY ARG GLU ASP THR SEQRES 5 B 233 ILE LYS ILE LEU ARG ASP ALA GLY TYR HIS VAL LYS ALA SEQRES 6 B 233 ASN GLY VAL ASP VAL THR THR HIS ARG GLN ASP ILE ASN SEQRES 7 B 233 GLY LYS GLU MET LYS PHE GLU VAL LEU THR LEU ALA SER SEQRES 8 B 233 LEU THR THR GLU ILE GLN ILE ASN ILE GLU ILE GLU SER SEQRES 9 B 233 ARG LYS SER TYR LYS LYS MET LEU LYS GLU MET GLY GLU SEQRES 10 B 233 VAL ALA PRO GLU TYR ARG HIS ASP SER PRO ASP CYS GLY SEQRES 11 B 233 MET ILE ILE LEU CYS ILE ALA ALA LEU VAL ILE THR LYS SEQRES 12 B 233 LEU ALA ALA GLY ASP ARG SER GLY LEU THR ALA VAL ILE SEQRES 13 B 233 ARG ARG ALA ASN ASN VAL LEU LYS ASN GLU MET LYS ARG SEQRES 14 B 233 TYR LYS GLY LEU LEU PRO LYS ASP ILE ALA ASN SER PHE SEQRES 15 B 233 TYR GLU VAL PHE GLU LYS HIS PRO HIS PHE ILE ASP VAL SEQRES 16 B 233 PHE VAL HIS PHE GLY ILE ALA GLN SER SER THR LYS GLY SEQRES 17 B 233 GLY SER ARG VAL GLU GLY ILE PHE ALA GLY LEU PHE MET SEQRES 18 B 233 ASN ALA TYR GLY LEU GLU HIS HIS HIS HIS HIS HIS HET PHE A 301 12 HET SO4 A1254 5 HET SO4 A1255 5 HET GOL A1256 6 HET PHE B 301 12 HET SO4 B1253 5 HET SO4 B1254 5 HET SO4 B1255 5 HET SO4 B1256 5 HET SO4 B1257 5 HET SO4 B1258 5 HET GOL B1259 6 HETNAM PHE PHENYLALANINE HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 PHE 2(C9 H11 N O2) FORMUL 4 SO4 8(O4 S 2-) FORMUL 6 GOL 2(C3 H8 O3) FORMUL 15 HOH *272(H2 O) HELIX 1 1 ASN A 37 ASP A 39 5 3 HELIX 2 2 VAL A 40 ILE A 53 1 14 HELIX 3 3 PHE A 61 GLY A 75 1 15 HELIX 4 4 GLY A 75 ALA A 86 1 12 HELIX 5 5 THR A 120 GLY A 143 1 24 HELIX 6 6 ALA A 146 ARG A 150 5 5 HELIX 7 7 ASP A 155 LYS A 170 1 16 HELIX 8 8 GLY A 178 LEU A 190 1 13 HELIX 9 9 LEU A 190 TYR A 197 1 8 HELIX 10 10 LEU A 201 HIS A 216 1 16 HELIX 11 11 PRO A 217 SER A 231 1 15 HELIX 12 12 SER A 237 ALA A 250 1 14 HELIX 13 13 ASN B 37 ASP B 39 5 3 HELIX 14 14 VAL B 40 ILE B 53 1 14 HELIX 15 15 PHE B 61 GLY B 75 1 15 HELIX 16 16 GLY B 75 ALA B 86 1 12 HELIX 17 17 THR B 120 GLY B 143 1 24 HELIX 18 18 ALA B 146 ARG B 150 5 5 HELIX 19 19 ASP B 155 THR B 169 1 15 HELIX 20 20 LYS B 170 GLY B 174 5 5 HELIX 21 21 GLY B 178 LEU B 190 1 13 HELIX 22 22 LEU B 190 TYR B 197 1 8 HELIX 23 23 LEU B 201 HIS B 216 1 16 HELIX 24 24 PRO B 217 SER B 232 1 16 HELIX 25 25 SER B 237 ASN B 249 1 13 SHEET 1 AA 2 ILE A 33 ASP A 34 0 SHEET 2 AA 2 ALA A 92 ASN A 93 1 N ASN A 93 O ILE A 33 SHEET 1 AB 2 VAL A 97 ILE A 104 0 SHEET 2 AB 2 LYS A 107 LEU A 114 -1 O LYS A 107 N ILE A 104 SHEET 1 BA 2 SER B 32 ASP B 34 0 SHEET 2 BA 2 LYS B 91 ASN B 93 1 O LYS B 91 N ILE B 33 SHEET 1 BB 2 VAL B 97 ILE B 104 0 SHEET 2 BB 2 LYS B 107 LEU B 114 -1 O LYS B 107 N ILE B 104 CISPEP 1 ALA A 172 ALA A 173 0 -1.60 SITE 1 AC1 7 SER A 131 ARG A 132 TYR A 135 HIS A 151 SITE 2 AC1 7 HOH A2090 ASP B 103 GLY B 106 SITE 1 AC2 5 ARG A 73 PHE A 226 ALA A 229 GLN A 230 SITE 2 AC2 5 THR A 233 SITE 1 AC3 2 SER A 32 ARG A 101 SITE 1 AC4 6 MET A 194 LYS A 195 ARG A 196 TYR A 197 SITE 2 AC4 6 LYS A 198 ARG B 184 SITE 1 AC5 6 ARG B 132 TYR B 135 ARG B 150 HIS B 151 SITE 2 AC5 6 SO4 B1253 HOH B2084 SITE 1 AC6 2 ARG B 132 PHE B 301 SITE 1 AC7 2 HIS B 100 ARG B 101 SITE 1 AC8 5 LYS A 81 ARG B 76 ARG B 84 ALA B 92 SITE 2 AC8 5 HOH B2134 SITE 1 AC9 3 LYS A 195 ALA B 181 ARG B 184 SITE 1 BC1 5 LYS B 81 SER B 237 ARG B 238 HOH B2135 SITE 2 BC1 5 HOH B2136 SITE 1 BC2 6 ARG A 150 ILE B 104 ASN B 105 LYS B 136 SITE 2 BC2 6 LYS B 140 HOH B2079 SITE 1 BC3 4 THR B 120 THR B 121 HOH B2060 HOH B2064 CRYST1 71.808 134.723 50.362 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013926 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007423 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019856 0.00000